Purchase human small airway epithelial primary cells
Ended Purchase Order Awarded
- Contract number
- 75N95020P00260
- Awardee
-
Lifeline Cell Technology, LLC UEI TVSAANLAZFY3 Part of International Stem Cell Corporation
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $26,921
Award facts
- Opportunity
-
- Acquisition of human small airway epithelial primary cells Solicitation · 75N95020Q00152 · Posted Jun 15, 2020
- Contract value 100% obligated
- $26,920.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21701, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
This contract was awarded by the National Center for Advancing Translational Sciences (NCATS), which is a civilian agency under the National Institutes of Health (NIH), to Lifeline Cell Technology, LLC, a subsidiary of International Stem Cell Corporation, to purchase human small airway epithelial primary cells. The cells are being acquired to develop a 3D vascularized lung model to mimic SARS-CoV-2 viral infection, in support of COVID-19 research. The contract has a firm fixed price of $26,920.84 and a completion date of July 31, 2020. No set-aside designation was used for this non-competitive, urgent acquisition.
Quick answers
Who was awarded contract 75N95020P00260?
75N95020P00260 was awarded to Lifeline Cell Technology, LLC by National Institute on Drug Abuse (National Institutes of Health) on June 29, 2020.
How much is contract 75N95020P00260 worth?
The government has obligated $26,921 on 75N95020P00260.
Which agency awarded contract 75N95020P00260?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00260, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95020P00260 competed?
The extent of competition for 75N95020P00260 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award